Bridges Investment Management’s AbbVie ABBV Stock Holding History

Bridges Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.7M	Buy	193,443 +7,350	+4%	+$1.58M	0.59%	43
2026 Q1	$40.5M	Sell	186,093 -1,294	-0.7%	-$287K	0.55%	48
2025 Q4	$42.8M	Sell	187,387 -4,702	-2%	-$1.07M	0.54%	45
2025 Q3	$44.5M	Buy	192,089 +2,117	+1%	+$431K	0.57%	47
2025 Q2	$35.3M	Sell	189,972 -2,059	-1%	-$383K	0.48%	52
2025 Q1	$40.2M	Buy	192,031 +12,165	+7%	+$2.36M	0.58%	46
2024 Q4	$32M	Sell	179,866 -420	-0.2%	-$77.2K	0.45%	53
2024 Q3	$35.6M	Sell	180,286 -753	-0.4%	-$141K	0.5%	50
2024 Q2	$31.1M	Buy	181,039 +100,547	+125%	+$16.7M	0.47%	49
2024 Q1	$14.7M	Sell	80,492 -1,943	-2%	-$335K	0.46%	50
2023 Q4	$12.8M	Buy	82,435 +2,279	+3%	+$332K	0.42%	52
2023 Q3	$11.9M	Sell	80,156 -14,047	-15%	-$2.06M	0.42%	53
2023 Q2	$12.7M	Sell	94,203 -10,568	-10%	-$1.55M	0.43%	55
2023 Q1	$16.7M	Buy	104,771 +701	+0.7%	+$107K	0.59%	45
2022 Q4	$16.8M	Buy	104,070 +2,862	+3%	+$439K	0.62%	45
2022 Q3	$13.6M	Sell	101,208 -2,384	-2%	-$342K	0.52%	48
2022 Q2	$15.9M	Sell	103,592 -4	-0%	-$611	0.58%	47
2022 Q1	$16.8M	Buy	103,596 +51	+0%	+$7.41K	0.52%	50
2021 Q4	$14M	Buy	103,545 +5,495	+6%	+$649K	0.41%	55
2021 Q3	$10.6M	Buy	98,050 +793	+0.8%	+$90.6K	0.33%	64
2021 Q2	$11M	Sell	97,257 -1,135	-1%	-$128K	0.33%	63
2021 Q1	$10.6M	Sell	98,392 -2,862	-3%	-$306K	0.31%	65
2020 Q4	$10.8M	Sell	101,254 -8,622	-8%	-$829K	0.33%	61
2020 Q3	$9.62M	Sell	109,876 -1,980	-2%	-$186K	0.33%	62
2020 Q2	$11M	Sell	111,856 -5,428	-5%	-$478K	0.4%	60
2020 Q1	$8.94M	Sell	117,284 -11,209	-9%	-$955K	0.4%	59
2019 Q4	$11.4M	Buy	128,493 +2,597	+2%	+$216K	0.42%	60
2019 Q3	$9.53M	Sell	125,896 -2,748	-2%	-$188K	0.36%	64
2019 Q2	$9.36M	Buy	128,644 +1,851	+1%	+$145K	0.36%	65
2019 Q1	$10.2M	Sell	126,793 -4,786	-4%	-$392K	0.42%	55
2018 Q4	$12.1M	Buy	131,579 +5,095	+4%	+$448K	0.57%	42
2018 Q3	$12M	Buy	126,484 +3,374	+3%	+$320K	0.59%	40
2018 Q2	$11.4M	Buy	123,110 +3,585	+3%	+$350K	0.51%	48
2018 Q1	$11.3M	Buy	119,525 +43,839	+58%	+$4.82M	0.52%	50
2017 Q4	$7.32M	Sell	75,686 -660	-0.9%	-$62.2K	0.59%	49
2017 Q3	$6.78M	Buy	76,346 +29,171	+62%	+$2.22M	0.64%	43
2017 Q2	$3.42M	Buy	47,175 +798	+2%	+$53.6K	0.46%	50
2017 Q1	$3.02M	Sell	46,377 -2,235	-5%	-$141K	0.42%	54
2016 Q4	$3.04M	Buy	48,612 +780	+2%	+$47.6K	0.43%	56
2016 Q3	$3.02M	Buy	47,832 +185	+0.4%	+$12K	0.5%	56
2016 Q2	$2.95M	Buy	47,647 +1,625	+4%	+$99K	0.51%	54
2016 Q1	$2.63M	Buy	46,022 +7,215	+19%	+$402K	0.48%	55
2015 Q4	$2.3M	Buy	38,807 +3,677	+10%	+$212K	0.41%	57
2015 Q3	$2.36M	Hold	35,130	–	–	0.41%	58
2015 Q2	$2.36M	Buy	35,130 +2,678	+8%	+$175K	0.41%	58
2015 Q1	$1.9M	Buy	32,452 +866	+3%	+$52.3K	0.33%	62
2014 Q4	$2.07M	Buy	31,586 +974	+3%	+$61.4K	0.37%	61
2014 Q3	$1.77M	Buy	30,612 +1,400	+5%	+$77.7K	0.33%	65
2014 Q2	$1.65M	Buy	29,212 +92	+0.3%	+$4.83K	0.31%	66
2014 Q1	$1.5M	Buy	29,120 +2,385	+9%	+$121K	0.31%	62
2013 Q4	$1.41M	Buy	26,735 +75	+0.3%	+$3.69K	0.32%	64
2013 Q3	$1.19M	Sell	26,660 -273	-1%	-$12.1K	0.3%	66
2013 Q2	$1.11M	Buy	+26,933	New	+$1.18M	0.29%	65

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bridges Investment Management's ABBV Position: Q2 2026 in Review

Bridges Investment Management increased its AbbVie (ABBV) stake by 3.9% in Q2 2026, buying an estimated $1.58M and bringing the position to 193,443 shares worth $48.7M. The position accounts for 0.59% of the portfolio, ranked #43.

Bridges Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Bridges Investment Management held 193,443 shares of AbbVie worth $48.7M as of Q2 2026.
Bridges Investment Management bought 7,350 AbbVie shares in Q2 2026, an estimated $1.58M.
AbbVie made up 0.59% of Bridges Investment Management's portfolio in Q2 2026, its #43 holding.
Bridges Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bridges Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.